Applications of miRNA technology for atherosclerosis

Hiroe Toba, Dolores Cortez, Merry L. Lindsey, Robert J. Chilton

Research output: Contribution to journalReview articlepeer-review

33 Scopus citations


MicroRNAs (miRNAs) are a class of post-transcriptional regulators that provide a mechanism of gene silencing by translational repression or degradation of the targeted gene. Gene expression regulation by miRNAs is involved in most if not all physiological and pathophysiological processes. Atherosclerosis is a major cardiovascular disease pathology regulated by miRNAs. Recent miRNA profiling studies have implicated the potential use of miRNAs as biomarkers in patients with atherosclerosis, as both diagnostic and prognostic indicators. This review will discuss the clinical and basic science research information that has been gleaned regarding miRNA roles in dyslipidemia, diabetes, obesity, and insulin resistance which are the major stimulators for the development of atherosclerosis.

Original languageEnglish (US)
Article number386
JournalCurrent atherosclerosis reports
Issue number2
StatePublished - Feb 2014
Externally publishedYes


  • Atherosclerosis
  • Cardiovascular disease
  • Diabetes
  • Hyperlipidemia
  • Insulin resistance
  • Matrix metalloproteinase
  • Metabolics
  • MicroRNA
  • Obesity
  • Proteomics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Applications of miRNA technology for atherosclerosis'. Together they form a unique fingerprint.

Cite this